Assessment of damage in vasculitis: Expert ratings of damage

Assessment of damage in vasculitis: Expert ratings of damage

Show other versions (1)

Bibliografske podrobnosti
Main Authors:	Seo, P, Jayne, DR, Luqmani, R, Merkel, P
Format:	Conference item
Izdano:	2008

Podobne knjige/članki

Assessment of damage in vasculitis: expert ratings of damage.
od: Seo, P, et al.
Izdano: (2009)

Assessment of damage in vasculitis: expert ranking of items of damage
od: Seo, P, et al.
Izdano: (2007)

The future of damage assessment in vasculitis.
od: Seo, P, et al.
Izdano: (2007)

Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index
od: Suppiah, R, et al.
Izdano: (2010)

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index.
od: Suppiah, R, et al.
Izdano: (2011)

MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA)
od: Suppiah, R, et al.
Izdano: (2010)

Damage assessment in ANCA-associated vasculitis.
od: Bhamra, K, et al.
Izdano: (2012)

276 The short-term damage burden in vasculitis and vasculitis mimics as measured by the vasculitis damage index
od: Floris, A, et al.
Izdano: (2016)

THE VASCULITIS DAMAGE INDEX (VDI)
od: Exley, A, et al.
Izdano: (1995)

Development of a score for assessment of radiologic damage in large-vessel vasculitis (Combined Arteritis Damage Score, CARDS)
od: Nakagomi, D, et al.
Izdano: (2017)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
od: Suppiah, R, et al.
Izdano: (2011)

Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI).
od: Exley, A, et al.
Izdano: (1998)

Functional outcome vs damage in systemic vasculitis
od: Exley, A, et al.
Izdano: (1996)

Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.
od: Exley, A, et al.
Izdano: (1997)

284 Differences in early damage patterns in various forms of primary systemic vasculitis
od: Wawrzycka-Adamczyk, K, et al.
Izdano: (2016)

The vasculitis damage index as a surrogate outcome measure in systemic vasculitis.
od: McRorie, E, et al.
Izdano: (1997)

Damage is independent of disease activity in systemic vasculitis
od: McRorie, E, et al.
Izdano: (1998)

Damage occurs early in systemic vasculitis and is an index of outcome.
od: Exley, A, et al.
Izdano: (1997)

Development of comprehensive disease assessment in systemic vasculitis.
od: Flossmann, O, et al.
Izdano: (2008)

Development of comprehensive disease assessment in systemic vasculitis.
od: Flossmann, O, et al.
Izdano: (2007)

REVIEW OF THE EXPERT PANEL METHODOLOGY IN THE DIAGNOSTIC AND CLASSIFICATION CRITERIA FOR VASCULITIS STUDY: A PILOT STUDY
od: Pante, C, et al.
Izdano: (2014)

Review Of The Expert Panel Methodology In The Diagnostic and Classification Criteria For Vasculitis Study: A Pilot Study
od: Ponte, C, et al.
Izdano: (2013)

Systemic vasculitis--is it time to reclassify?
od: Watts, R, et al.
Izdano: (2011)

TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
od: Robson, J, et al.
Izdano: (2013)

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).
od: Luqmani, R, et al.
Izdano: (2011)

VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis.
od: Bacon, P, et al.
Izdano: (1995)

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials.
od: Robson, J, et al.
Izdano: (2015)

Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
od: Robson, J, et al.
Izdano: (2015)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
od: Walsh, M, et al.
Izdano: (2011)

Disease assessment in systemic vasculitis
od: Luqmani, R
Izdano: (2004)

FACTORS ASSOCIATED WITH LONG-TERM DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF COHORTS FROM THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
od: Robson, J, et al.
Izdano: (2013)

DIAGNOSIS AND ASSESSMENT OF LARGE VESSEL VASCULITIS
od: Luqmani, R
Izdano: (2011)

Assessment of systemic vasculitis.
od: Miller, A, et al.
Izdano: (2008)

Vasculitis damage index in Behçet’s disease
od: Fatema T. Elgengehy, et al.
Izdano: (2021-06-01)

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.
od: Robson, J, et al.
Izdano: (2014)

Cutaneous manifestations of ANCA-associated vasculitis
od: Chiesafuxench, Z, et al.
Izdano: (2016)

The role of biologic therapies in the management of systemic vasculitis.
od: Chan, A, et al.
Izdano: (2006)

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
od: Yates, M, et al.
Izdano: (2017)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
od: Flossmann, O, et al.
Izdano: (2006)

ANCA Associated Vasculitis Subtypes: Response [Letter]
od: Merkel PA, et al.
Izdano: (2022-09-01)